WallStreetZenWallStreetZen

NYSE: WST
West Pharmaceutical Services Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
West Pharmaceutical Services earnings were $487.7M for the trailing 12 months ending Jun 30, 2025, with -5.5% growth year over year. The latest WST earnings report on Jun 30, 2025 announced Q2 2025 earnings of $131.8M, up 46.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, WST reported annual earnings of $492.7M, with -17% growth.

WST past earnings growth

How has WST's earnings growth performed historically?

Company
-5.49%
Industry
16.75%
Market
30.36%
WST's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
WST's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
WST's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

WST earnings history

Current Revenue
$3.0B
Current Earnings
$487.7M
Current Profit Margin
16.5%
WST's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

WST Return on Equity

Current Company
17.7%
Current Industry
10.7%
Current Market
27.2%
WST's Return on Equity (17.7%)... subscribe to Premium to read more.
High Return on Equity Performance

WST undefined

Current Company
13.1%
Current Industry
9%
WST is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when WST announces earnings.

WST undefined

Current Company
18.27%
Current Industry
11.6%
WST's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

WST vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
WST$773.90M$487.70M+11.61%$6.72
HOLX$1.09B$557.10M+5.27%$2.43
COO$1.14B$414.20M+3.69%$2.08
BAX$941.00M-$155.00MN/A-$0.30
ATR$809.13M$391.50M+13.34%$5.91
View Top Medical Stocks

West Pharmaceutical Services Earnings Reports & History FAQ

What were West Pharmaceutical Services's earnings last quarter?

On WST's earnings call on Invalid Date, West Pharmaceutical Services (NYSE: WST) reported Q2 2025 earnings per share (EPS) of $1.82, up 19.74% year over year. Total WST earnings for the quarter were $131.80 million. In the same quarter last year, West Pharmaceutical Services's earnings per share (EPS) was $1.52.

If you're new to stock investing, here's how to buy West Pharmaceutical Services stock.

Is West Pharmaceutical Services profitable or losing money?

As of the last West Pharmaceutical Services earnings report, West Pharmaceutical Services is currently profitable. West Pharmaceutical Services's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $487.70 million, a 7.09% decrease year over year.

What was WST's earnings growth in the past year?

As of West Pharmaceutical Services's earnings date in Invalid Date, West Pharmaceutical Services's earnings has grown -5.49% year over year. This is 22.23 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 16.75%. WST earnings in the past year totalled $487.70 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.